PAVmed Inc. (PAVM)
PAVM moved a median of -0.49% 30 minutes after news, and -0.67% by the close. How PAVM actually reacts to news — the realized, point-in-time move the market made, measured across 193 labeled events over the last three years with zero look-ahead.
PAVM’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 40% | 178 |
| 30-min | -0.49% | 41% | 188 |
| 60-min | +0.32% | 56% | 191 |
| to close | -0.67% | 44% | 189 |
| Middle 50% of PAVM reactions | -2.24% to +1.89% |
|---|---|
| Median reaction (30-min) | -0.49% |
| Measured reactions | 193 |
Half of all PAVmed Inc. news events land between -2.24% and +1.89% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when PAVM moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to PAVM's baseline. Nothing else.
Recent PAVM events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K PAVmed Inc. For: Sep 09 | SEC filing · Form 8-K | SEC EDGAR | — | -5.11% | |
| Form 8-K PAVmed Inc. For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | — | +12.80% | |
| PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results | Press release | PR Newswire | +2.55% | +10.64% | |
| Form 10-Q PAVmed Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +2.55% | +10.64% | |
| PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026 | Press release | PR Newswire | — | -1.39% | |
| Form S-8 PAVmed Inc. | SEC filing · Form S-8 | SEC EDGAR | +0.00% | -2.03% | |
| Form 8-K PAVmed Inc. For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | +5.00% | -5.43% | |
| Form 8-K PAVmed Inc. For: May 15 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.19% | |
| PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results | Press release | PR Newswire | +0.00% | +2.19% | |
| Form 10-Q PAVmed Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +2.19% | |
| Form DEF 14A PAVmed Inc. For: Apr 30 | SEC filing · Form DEF | SEC EDGAR | — | +0.71% | |
| PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 | Press release | PR Newswire | — | +0.71% | |
| Form ARS PAVmed Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | — | +0.71% | |
| Form DEFA14A PAVmed Inc. | SEC filing · Form DEFA14A | SEC EDGAR | — | +0.71% | |
| Form EFFECT PAVmed Inc. | SEC filing · Form EFFECT | SEC EDGAR | — | -5.79% | |
| Form S-3 PAVmed Inc. | SEC filing · Form S-3 | SEC EDGAR | +1.97% | +0.05% | |
| Form S-8 PAVmed Inc. | SEC filing · Form S-8 | SEC EDGAR | -1.79% | -1.89% | |
| PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio | Press release | PR Newswire | -1.79% | -1.89% | |
| Form 8-K PAVmed Inc. For: Mar 30 | SEC filing · Form 8-K | SEC EDGAR | +1.85% | +11.49% | |
| PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results | Press release | PR Newswire | +1.85% | +11.49% | |
| Form 10-K PAVmed Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +1.85% | +11.49% | |
| Form 8-K PAVmed Inc. For: Mar 27 | SEC filing · Form 8-K | SEC EDGAR | +1.85% | +11.49% | |
| PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026 | Press release | PR Newswire | +0.00% | -0.98% | |
| Form DEF 14A PAVmed Inc. For: Feb 24 | SEC filing · Form DEF | SEC EDGAR | +1.66% | +7.90% | |
| Form D PAVmed Inc. | SEC filing · Form D | SEC EDGAR | -5.32% | -1.06% | |
| Form PRE 14A PAVmed Inc. For: Feb 13 | SEC filing · Form PRE | SEC EDGAR | -5.32% | -1.06% | |
| Form 8-K PAVmed Inc. For: Feb 03 | SEC filing · Form 8-K | SEC EDGAR | +2.48% | +0.00% | |
| PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities | Press release | PR Newswire | +2.48% | +0.00% | |
| Form 8-K PAVmed Inc. For: Jan 21 | SEC filing · Form 8-K | SEC EDGAR | +5.54% | +9.50% | |
| Form 8-K PAVmed Inc. For: Dec 30 | SEC filing · Form 8-K | SEC EDGAR | -3.04% | -15.71% | |
| PAVmed Announces Reverse Stock Split | Press release | PR Newswire | -3.04% | -15.71% | |
| Form 8-K PAVmed Inc. For: Dec 05 | SEC filing · Form 8-K | SEC EDGAR | +2.50% | +8.31% | |
| Form 8-K PAVmed Inc. For: Nov 13 | SEC filing · Form 8-K | SEC EDGAR | -1.84% | — | |
| PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results | Press release | PR Newswire | -1.84% | — | |
| Form 10-Q PAVmed Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.84% | — | |
| Form DEF 14A PAVmed Inc. For: Oct 31 | SEC filing · Form DEF | SEC EDGAR | +0.61% | -5.88% | |
| PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025 | Press release | PR Newswire | -2.29% | -3.98% | |
| Form PRE 14A PAVmed Inc. For: Oct 20 | SEC filing · Form PRE | SEC EDGAR | -2.21% | -5.21% | |
| PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement | Press release | PR Newswire | +0.70% | +3.32% | |
| Form 8-K PAVmed Inc. For: Sep 11 | SEC filing · Form 8-K | SEC EDGAR | -0.02% | +1.04% | |
| PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology | Press release | PR Newswire | +0.06% | +3.84% | |
| Form 8-K PAVmed Inc. For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | -0.72% | -3.25% | |
| PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results | Press release | PR Newswire | -0.72% | -3.25% | |
| PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025 | Press release | PR Newswire | +1.34% | +2.80% | |
| Form 8-K PAVmed Inc. For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.41% | |
| PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule | Press release | PR Newswire | +0.00% | -2.41% | |
| Form S-8 PAVmed Inc. | SEC filing · Form S-8 | SEC EDGAR | +1.40% | — | |
| Form 8-K PAVmed Inc. For: Jun 23 | SEC filing · Form 8-K | SEC EDGAR | +2.87% | -0.41% | |
| PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing | Press release | PR Newswire | +2.87% | -0.41% | |
| Form 8-K PAVmed Inc. For: Jun 18 | SEC filing · Form 8-K | SEC EDGAR | -1.43% | -7.94% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the PAVM section they belong to.
Where else PAVM is measured.
PAVM earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GENMAB A/S DKK (GNMSF) | 193 | 0.00% | 22% |
| HARBOR DIVERSIFIED INC (HRBR) | 193 | 0.00% | 38% |
| SIENNA BIOPHARMACEUTICALS (SNNA) | 193 | 0.00% | 40% |
| Spero Therapeutics, Inc. (SPRO) | 193 | +0.01% | 54% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is PAVmed Inc.'s median reaction calculated?
Every labeled PAVM news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 193 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 41% of PAVM's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does PAVM's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.